Genetics of familial and sporadic Alzheimer s disease

Piaceri, Irene·2013·Frontiers in Bioscience
DOI 10.2741/e605

Cited by (256)

Items 201–256 of 256

  1. PROSPECTS FOR USE OF SHORT PEPTIDES IN PHARMACOTHERAPEUTIC CORRECTION OF ALZHEIMER’S DISEASE
    Anastasiia Ilina, Irina G. Popovich, Galina Anatol’evna Ryzhak, В.Х. Хавинсон · 2024 · Успехи геронтологии
  2. Impaired Dynamics of Positional and Contextual Neural Coding in an Alzheimer’s Disease Rat Model
    Athira Nataraj, Annu Kala, Stephanie L. Proskauer Pena, Karel Ježek, Karel Blahna · 2024 · Journal of Alzheimer s Disease
  3. The Role of Hormone Replacement Therapy (HRT) for the Prevention of Alzheimer's Disease in Postmenopausal Women
    Karla Littleford, Laura Tyler, Mark Dashwood, Hannah Reed, Tarun Kuruvilla · 2024 · Progress in Neurology and Psychiatry
  4. 1H NMR-Based Metabolomic Signatures in Rodent Models of Sporadic Alzheimer’s Disease and Metabolic Disorders
    Ananya Shukla, Khushbhu Meena, Ashish K Gupta, Rajat Sandhir · 2024 · ACS Chemical Neuroscience
  5. Comparison and aggregation of event sequences across ten cohorts to describe the consensus biomarker evolution in Alzheimer’s disease
    Sepehr Golriz Khatami, Yasamin Salimi, Martin Hofmann‐Apitius, Neil P. Oxtoby, Colin J. Birkenbihl, Alzheimer’s Disease Neuroimaging Initiative, the Japanese Alzheimer’s Disease Neuroimaging Initiative, the Alzheimer’s Disease Repository Without Borders Investigators · 2021 · medRxiv
  6. Neurologic Diseases
    Eric T. Stoopler, Michael L. McGarvey · 2021
  7. Implications of Human Umbilical Cord Blood Cells: An Immunotherapeutic Strategy for Alzheimer's Disease
    Donna Darlington · 2014 · Digital Commons - University of South Florida (University of South Florida)
  8. Role of TTR in A β peptide brain efflux - Impact in Alzheimer's disease
    Cristiana Gaiteiro · 2014 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  9. Molecular Mechanisms of Neuroprotection and Cognitive Enhancement by an Alternative drug Centella asiatica
    Manuj Ahuja · 2013
  10. Targeting Nanoparticles to Brain: Impact of N-Methyl d-Aspartate Receptors
    Ayşe Başak Engin · 2017 · Springer eBooks
  11. The problem of cervical dysplasia.
    H D Wood, JOHN F. J. CLARK · 1969 · PubMed Central
  12. Using Bioengineering Approaches to Generate a Three-Dimensional Human Induced Pluripotent Stem-Cell Based Model of Alzheimer's Disease
    Rachel A. Lundeen · 2017 · Arizona State University Library Digital Repository (Arizona State University)
  13. Molecular determinants of astrocyte morpho-functional changes in Alzheimer’s disease
    Norah Elisa Ulzheimer · 2019 · CLOK (University of Central Lancashire)
  14. IPSC-derived GRN-mutant astrocytes delay excitatory electrical development of neurons in a non-cell autonomous manner
    Lee, Christopher · 2021 · cIRcle (University of British Columbia)
  15. Molecular basis of amyloid-β chaperone activity of lipocalin-type prostaglandin D synthase (L-PGDS)
    Bhuvaneswari Kannaian · 2019
  16. MicroRNAs in Blood Serum, Blood Plasma, and Cerebrospinal Fluid as Diagnostic Biomarkers of Alzheimer’s Disease
    Philip V. Peplow, Bridget Martinez · 2021 · Neuromethods
  17. Amyloid beta resistance and the Warburg effect: Re-examining Alzheimer's disease
    Jordan T. Newington · 2013 · Scholarship@Western (Western University)
  18. Pathogénie et physiopathologie de la maladie d’Alzheimer
    Olivier Nicole · 2022 · Elsevier eBooks
  19. Neurodegenerative Diseases Involve Multifactorial Interplay of Genetics and Environmental Factors
    Tabish Qidwai · 2022 · BENTHAM SCIENCE PUBLISHERS eBooks
  20. Role of the Nrf2/ARE downregulation and mtDNA damage in the cognitive impairments in APP/PS1 mice
    Artem P. Gureev, Polina I. Babenkova, Veronika V. Nesterova, Arina D. Tsvetkova, Irina S. Sadovnikova, Anna A. Eremina, Vera A. Kryukova, Vasily N. Popov · 2023 · Research Square
  21. Segmenting the human brain in population-based studies
    Jennifer Monereo Sánchez · 2023
  22. Cellular prion protein in Alzheimer’s disease: Molecular insights and behavior implications
    Angela da Silva Correia · 2024
  23. Human endogenous retroviruses are upregulated in Frontotemporal Dementia-MAPT mutation carriers
    Laura Fort‐Aznar, Sergi Borrego‐Écija, Laura Molina‐Porcel, Aina Comas‐Albertí, Roger Puey, Alba Gómez, Mircea Balasa, Albert Lladó, Anna Antonell, Raquel Sánchez‐Valle · 2024 · Research Square
  24. Discovery of small molecules from natural compound databases as potent retinoid X alpha receptor agonists to treat Alzheimer’s disease
    Alireza Rahimpour, Behzad Shahbazi, Ladan Mafakher · 2024 · Journal of Biomolecular Structure and Dynamics
  25. Experimental Animal Models in Neurological Diseases
    Neslihan Şirin, Şerif Demír · 2024 · Düzce Tıp Fakültesi Dergisi
  26. Patient-Reported Characteristics of Pernicious Anaemia: A first step to initiate James Lind Alliance Priority Setting Partnership Driven Research
    Alfie Thain, Petra Visser, Kathryn H. Hart, Ebba Nexø, Andrew McCaddon, Luciana Hannibal, Bruce H. R. Wolffenbuttel, Ralph Green, Nicola Ward, Catherine Heidi Seage et al. · 2024 · medRxiv
  27. Prevention and Reduction of Risk of AD: Lifestyle Changes, Dietary Changes, Supplements, and More
    Ashish Sriram Mishra, Manimaran Vasanthan, Swati Swagatika Swain, Veera Venkata Satyanarayana Reddy Karri · 2024 · Springer eBooks
  28. Perspective on Tau Hypothesis in Alzheimer’s Disease: Traversing the Therapeutic Potential of Flavonoids
    Dipender kumari, Manjusha Choudhary, Prabhjeet Kaur Bamrah, Aditya Malan, Nitesh nitesh · 2025 · The Natural Products Journal
  29. Physiological Changes Linked with Alzheimer’s Disease and Related Dementias
    Ameanté Payen, James R. Bateman, Dana Miller, Sneha Dhanavanthri Muralidhara, Jeanette M. Bennett · 2024 · Springer eBooks
  30. Translational pharmacology and biomarkers applied to GPCR
    Dennis Özcelik, Filippo Andreetta, Elizabeth Louise van der Kam · 2025 · Elsevier eBooks
  31. Physiological Changes Linked with Alzheimer’s Disease and Related Dementias
    Ameanté Payen, James R. Bateman, Dana Miller, Sneha Dhanavanthri Muralidhara, Jeanette M. Bennett · 2025 · Springer eBooks
  32. Whole Exome Sequencing Reveals Novel Genetic Mutations in the ADAM10 Underlying Familial Alzheimer’s Disease
    Aman Ullah, Sadaf Iftikhar · 2025 · Current Genetic Medicine Reports
  33. Pleiotrophin and receptor protein tyrosine phosphatase β/ζ as key modulators of high-fat diet-induced cognitive impairment and brain alterations
    Héctor Cañeque‐Rufo, Teresa Fontán‐Baselga, Elisa Rivera-Illades, Marta Vicente‐Rodríguez, Esther Gramage, José María Zapico, Beatriz de Pascual‐Teresa, Pilar Ramos, Gonzalo Herradón · 2025 · Biomedicine & Pharmacotherapy
  34. Alzheimer’s Disease: Pathophysiological and Therapeutical Insights
    Komal Tyagi, Prerna Sarup, Jai Malik · 2025 · Nutritional neurosciences
  35. Exploring the genetic frontier: Unraveling ANRIL, PAI-1, and HNF1α in stroke progression
    Abdullah Hamadi, Rashid Mir, Osama M. Al‐Amer, Mohammed Alasseiri, Gasim Dobie, Imadeldin Elfaki, Waseem AlZamzami, Sael M. Alatawi, Atif Abdulwahab A. Oyouni, Mohammad A. Alanazi et al. · 2025 · PLoS ONE
  36. Additional file 2 of Titanium dioxide and carbon black nanoparticles disrupt neuronal homeostasis via excessive activation of cellular prion protein signaling
    Luiz W. Ribeiro, Mathéa Pietri, Héctor Ardila-Osorio, Anne Baudry, François Boudet-Devaud, Chloé Bizingre, Zaira E. Arellano-Anaya, Anne‐Marie Haeberlé, Nicolas Gadot, Sonja Boland et al. · 2022 · Figshare
  37. Additional file 4 of Titanium dioxide and carbon black nanoparticles disrupt neuronal homeostasis via excessive activation of cellular prion protein signaling
    Luiz W. Ribeiro, Mathéa Pietri, Héctor Ardila-Osorio, Anne Baudry, François Boudet-Devaud, Chloé Bizingre, Zaira E. Arellano-Anaya, Anne‐Marie Haeberlé, Nicolas Gadot, Sonja Boland et al. · 2022 · Figshare
  38. Additional file 5 of Titanium dioxide and carbon black nanoparticles disrupt neuronal homeostasis via excessive activation of cellular prion protein signaling
    Luiz W. Ribeiro, Mathéa Pietri, Héctor Ardila-Osorio, Anne Baudry, François Boudet-Devaud, Chloé Bizingre, Zaira E. Arellano-Anaya, Anne‐Marie Haeberlé, Nicolas Gadot, Sonja Boland et al. · 2022 · Figshare
  39. Additional file 3 of Titanium dioxide and carbon black nanoparticles disrupt neuronal homeostasis via excessive activation of cellular prion protein signaling
    Luiz W. Ribeiro, Mathéa Pietri, Héctor Ardila-Osorio, Anne Baudry, François Boudet-Devaud, Chloé Bizingre, Zaira E. Arellano-Anaya, Anne‐Marie Haeberlé, Nicolas Gadot, Sonja Boland et al. · 2022 · Figshare
  40. Additional file 1 of Comparison and aggregation of event sequences across ten cohorts to describe the consensus biomarker evolution in Alzheimer’s disease
    Golriz Khatami, Sepehr, Yasamin Salimi, Martin Hofmann‐Apitius, Neil P. Oxtoby, Colin Birkenbihl · 2022 · Figshare
  41. Additional file 1 of Titanium dioxide and carbon black nanoparticles disrupt neuronal homeostasis via excessive activation of cellular prion protein signaling
    Luiz W. Ribeiro, Mathéa Pietri, Héctor Ardila-Osorio, Anne Baudry, François Boudet-Devaud, Chloé Bizingre, Zaira E. Arellano-Anaya, Anne‐Marie Haeberlé, Nicolas Gadot, Sonja Boland et al. · 2022 · Figshare
  42. Review on Role of Cerebrospinal Fluid and Blood Biomarkers in Alzheimer’s Disease Diagnosis
    Pydikondala Nehitha Purna, Pydiraju Kondrapu, Alekhya Ketha, Shashikala Metri, Nagaraju Bandaru · 2025 · Biomedical & Pharmacology Journal
  43. Etudes de trois métalloprotéases matricielles, MT1-MMP, MT5-MMP et MMP-12 dans l'amyloïdogenèse et les atteintes inflammatoires et vasculaires associées à la maladie d'Alzheimer
    Amandine Bonnet · 2017 · theses.fr (ABES)
  44. Clustering hinders APP α-secretase processing in the plasma membrane
    Kerstin Pinkwart, Thorsten Lang · 2026 · Biophysical Journal
  45. La protéine prion cellulaire : un relai de neurotoxicité commun aux protéines amyloïdes et aux nanoparticules
    François Boudet-Devaud · 2018 · theses.fr (ABES)
  46. Membranes biomimétiques pour la caractérisation de nouveaux agents thérapeutiques : application à la maladie d'Alzheimer
    Willy Smeralda · 2019 · theses.fr (ABES)
  47. Développement et caractérisation de modèles animaux de la maladie d'Alzheimer et de la polykystose rénale
    Svenja Koslowski · 2020
  48. Implication physio-pathologique de l'axe de signalisation PrPC-ADAM10/17 : des maladies neurodégénératives aux cancers
    Chloé Bizingre · 2024 · theses.fr (ABES)
  49. Regulation of Alzheimer pathology by amyloid seeds : from toxic effects to therapeutic opportunities, in mouse model of amyloidosis
    Marina Célestine · 2023 · theses.fr (ABES)
  50. Implication de la protéine prion cellulaire dans la neurotoxicité de protéines amyloïdes et de nanoparticules
    Luiz W. Ribeiro · 2023 · theses.fr (ABES)
  51. Emerging Pharmacological Innovation in Alzheimer’s Treatment
    Arvind Kumar Patel, Manish P. Singh, Shivam Kumar, Shankul Kumar, Neha Singh, Neetu Sachan, Phool Chandra · 2026 · BENTHAM SCIENCE PUBLISHERS eBooks
  52. Targeting the Nrf2 Signaling Pathway: A Review of Traditional Chinese Medicine for Alzheimer’s Disease
    Ming Liu, Hang Hong, Xingxing Zhang, Jiayu Ren, Chunlan Tang · 2026 · The American Journal of Chinese Medicine
  53. Neuroinflammation, Pericyte Dysfunction, and Alzheimer’s Disease-Associated Gene Expression and Pathway Activation in the Brain of SARS-CoV-2-Infected Mice
    Akinkunmi O. Lawal, Ikechukwu B. Jacob, Vignesh Karnik, Hongkuan Fan, Saravanan Thangamani, Paul T. Massa, Guirong Wang · 2026 · Viruses
  54. Alzheimer Hastalığında NHE6
    İrem Gülfem ALBAYRAK · 2026 · Akademisyen Kitabevi eBooks
  55. Non-transgenic rodent models associated with Alzheimer’s disease: applications, evaluations, and perspectives
    Shu Xing, Ping Ren, Zhuangfei Chen, Yu Fu · 2026 · Neuroscience
  56. Amyloid-β peptide and mitochondrial dysfunction
    Alexander J.T. Yang, Heather Wilkins · 2026 · Elsevier eBooks